Articles
Management of dyslipidaemia in patients with comorbidities – facing the challenge Value and limitations of lipid lowering drugs in liver disease Effects/Interactions of lipid-lowering agents on/with the liver
Frühwald L, Fasching P, Dobrev D, et al.
Journal:
Eur Heart J Cardiovasc Pharmacother
First published: December 24, 2024 DOI: 10.1093/ehjcvp/pvae095